Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases

Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases

Patients with brain metastases of HER2-positive breast cancer (BC) is a special group of patients who are difficult to treat and have a short life expectancy. The possibilities of whole brain radiotherapy, stereotactic radiosurgery and surgery in such patients are rather limited. Trastuzumab emtansi...

Full description

Bibliographic Details
Main Authors: L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, M. O. Ezhova, V. S. Myagkova, L. K. Strakhova
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-12-01
Series:Медицинский совет
Subjects:
trastuzumab emtansine
t-dm1
metastatic her2-positive
breast cancer
metastases
brain
Online Access:https://www.med-sovet.pro/jour/article/view/5953

Internet

https://www.med-sovet.pro/jour/article/view/5953

Similar Items